UK Health Secretary Wes Streeting announced an indefinite ban on prescribing puberty blockers to individuals under 18 questioning their gender identity. This decision follows a consultation with the Commission on Human Medicines, which deemed the practices surrounding the drugs as a ‘scandal’ and an ‘unacceptable safety risk.’ Streeting emphasized the need for evidence-based health care, noting prior instances where children received prescriptions with minimal oversight.